From: Dan Kuespert <dkuespert**At_Symbol_Here**JHU.EDU>
Subject: Re: [DCHAS-L] Using Cisplatin and other chemotherapy drugs
Date: Wed, 27 May 2015 11:29:31 +0000
Reply-To: DCHAS-L <DCHAS-L**At_Symbol_Here**MED.CORNELL.EDU>
Message-ID: BFC1080B-AE41-4EC8-AC01-73A8ED623353**At_Symbol_Here**
In-Reply-To <0413554c09094b8686beaffe963c06f7**At_Symbol_Here**>

I can put you in touch with one of our materials science research groups that uses doxorubicin. They don't do animal work (primarily cell culture and quantum dots), but they have a nice SOP that they would probably be willing to share. I've got a copy I could send you but I don't think it's the latest version.


Dr. Daniel R. Kuespert
Homewood Laboratory Safety Advocate
Krieger School of Arts & Sciences/Whiting School of Engineering
The Johns Hopkins University
103G Shaffer Hall
3400 North Charles St.
Baltimore, MD 21218
(410) 516-5525

On May 26, 2015, at 10:40, Yanchisin, Mark <mark**At_Symbol_Here**EHS.UFL.EDU> wrote: